FOSTER CITY, CA--(Marketwire - September 16, 2008) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York. Friedhelm Blobel, Ph.D., SciClone’s President and Chief Executive Officer, will present a corporate overview and business update on Thursday, September 25, 2008 at 1:00 pm ET.
